Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Price-Fixing 'Cartel,' Ohio Abortion Ban And J&J 340B Audits No Photo Available

Gianna Ferrarin

The American Medical Association has lobbed an antitrust suit against data firm MultiPlan and a state court struck down Ohio's "heartb... (more story)

Fla. Health Agency's All-Out Battle Against Abortion Measure No Photo Available

Theresa Schliep

Florida's health agencies are testing the limits of their power — and generating plenty of controversy in and outside of court — for t... (more story)

Beyond Abortion, 7 Ballot Questions Set To Shape Care No Photo Available

Dan McKay

While reproductive rights have led the healthcare debate this election season, voters across the country will shape state policies on ... (more story)